The Burden of Seasonal Influenza and Its Potential Complications Among Older Japanese Adults: A Real-World Database Study
- PMID: 39533850
- PMCID: PMC11557991
- DOI: 10.1111/irv.70032
The Burden of Seasonal Influenza and Its Potential Complications Among Older Japanese Adults: A Real-World Database Study
Abstract
Background: Seasonal influenza may lead to severe complications, including respiratory and cardiovascular disease, that result in considerable healthcare resource utilization (HCRU) and mortality, particularly in older individuals. This real-world study assessed the burden of influenza and its potential complications in older Japanese adults.
Methods: This retrospective claims database analysis (April 2015 to June 2019) included insured individuals aged ≥ 60 years at the start of four consecutive influenza seasons in Japan (October 1 to April 30). The primary endpoint was the incidence of influenza-related emergency room (ER) and outpatient visits, the incidence of hospitalizations, the probability of 30-day inpatient mortality, and 60-day medical costs of influenza or its potential complications.
Results: Of 8,974,708 individuals (43.2% male, mean ± standard deviation age 73.8 ± 8.9 years), 370,430 (4.13%) were diagnosed with influenza. Overall, 17.18 (95% confidence interval [CI] 16.32-18.04) and 3893.53 (3880.87-3906.19) per 100,000 individuals had influenza-related ER and outpatient visits, respectively, and 181.50 (178.71-184.28) per 100,000 individuals were hospitalized for influenza. The incidence of influenza-related ER visits and hospitalizations for influenza or potential complications and the probability of 30-day inpatient mortality increased with age.
Conclusions: Seasonal influenza and its potential complications represent a substantial burden that increases with age in Japanese individuals.
Keywords: Japan; aged; healthcare costs; hospitalization; human; influenza; mortality.
© 2024 The Author(s). Influenza and Other Respiratory Viruses published by John Wiley & Sons Ltd.
Conflict of interest statement
All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship, take responsibility for the integrity of the work as a whole, and have given their approval for this version to be published.
Takeshi Arashiro is a cooperative researcher with the National Institute of Infectious Diseases, Japan, and is an employee of Sanofi K.K. Yuki Tajima is an employee of Sanofi K.K. Yohei Ban has received consultancy fees from Sanofi K.K. and is an employee of Intage Healthcare Inc. Masayo Ideguchi is a full‐time employee of Sanofi K.K. and holds stock and/or stock options in the company. Matthew M Loiacono and Caroline de Courville are full‐time employees of Sanofi and hold stock and/or stock options in the company.
Figures


Similar articles
-
The Hospital Burden of Flu in Italy: a retrospective study on administrative data from season 2014-2015 to 2018-2019.BMC Infect Dis. 2024 Jun 8;24(1):572. doi: 10.1186/s12879-024-09446-2. BMC Infect Dis. 2024. PMID: 38851739 Free PMC article.
-
Economic burden and secondary complications of influenza-related hospitalization among adults in the US: a retrospective cohort study.J Med Econ. 2024 Jan-Dec;27(1):324-336. doi: 10.1080/13696998.2024.2314429. Epub 2024 Feb 22. J Med Econ. 2024. PMID: 38343288
-
Incidence of Influenza-related Medical Encounters and the Associated Healthcare Resource Use and Complications Across Adult Age Groups in the United States During the 2015-2020 Influenza Seasons.Clin Infect Dis. 2024 Sep 26;79(3):778-786. doi: 10.1093/cid/ciae180. Clin Infect Dis. 2024. PMID: 38567481 Free PMC article.
-
The Cost of Seasonal Influenza: A Systematic Literature Review on the Humanistic and Economic Burden of Influenza in Older (≥ 65 Years Old) Adults.Adv Ther. 2024 Mar;41(3):945-966. doi: 10.1007/s12325-023-02770-0. Epub 2024 Jan 23. Adv Ther. 2024. PMID: 38261171 Free PMC article.
-
Influenza-associated disease burden in mainland China: a systematic review and meta-analysis.Sci Rep. 2021 Feb 3;11(1):2886. doi: 10.1038/s41598-021-82161-z. Sci Rep. 2021. PMID: 33536462 Free PMC article.
Cited by
-
Cost-Effectiveness Analysis of Influenza Treatments in Japan Using a Transmission Model: The Impact of Baloxavir and Oseltamivir Shares.Infect Dis Ther. 2025 Aug 27. doi: 10.1007/s40121-025-01203-5. Online ahead of print. Infect Dis Ther. 2025. PMID: 40864406
References
-
- World Health Organization . Influenza (seasonal): fact sheet. 2023; Available at: https://www.who.int/news‐room/fact‐sheets/detail/influenza‐(seasonal). Accessed October 30, 2023.
-
- Japanese Association for Infectious Diseases . Influenza (seasonal) [in Japanese]. 2019; Available at: https://www.kansensho.or.jp/ref/d04.html. Accessed August 8, 2023.
-
- Warren‐Gash C., Blackburn R., Whitaker H., McMenamin J., and Hayward A. C., “Laboratory‐Confirmed Respiratory Infections as Triggers for Acute Myocardial Infarction and Stroke: A Self‐Controlled Case Series Analysis of National Linked Datasets From Scotland,” The European Respiratory Journal 51, no. 3 (2018): 1701794. - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous